Skip to content

Clinical trials

Completed Phase 2 Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Status: Completed Clear all

481 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200020
200113
200211
200318
200417
200523
200623
200726
200831
200923
201017
201131
201220
201336
201412
201525
201619
201714
201815
201911
202012
20215
20226
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed481

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center47
Fred Hutchinson Cancer Center36
National Cancer Institute (NCI)26
Memorial Sloan Kettering Cancer Center15
National Heart, Lung, and Blood Institute (NHLBI)13
Masonic Cancer Center, University of Minnesota12
Case Comprehensive Cancer Center11
Novartis Pharmaceuticals10
Roswell Park Cancer Institute6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute481
Myelodysplastic Syndromes188
Leukemia164
Precursor Cell Lymphoblastic Leukemia-Lymphoma147
Leukemia, Lymphocytic, Chronic, B-Cell93
Lymphoma, Non-Hodgkin90
Congenital Abnormalities88
Hodgkin Disease84
Leukemia, Myelogenous, Chronic, BCR-ABL Positive73
Multiple Myeloma70

Trials

Showing 1 to 25 of 481. Each trial links to its page on Pharma Observatory.

381 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.